• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Avantogen Oncology Inc

+ Add to Watchlist

AVTO:US

0.0100 USD 0.00000.00%

As of 20:10:00 ET on 07/21/2014.

Snapshot for Avantogen Oncology Inc (AVTO)

Open: - Day's Range: - Volume: 100
Previous Close: 0.0100 52wk Range: 0.0031 - 0.0200 1-Yr Rtn: -

Stock Chart for AVTO

No chart data available.
  • AVTO:US 0.0100
  • 1D
  • 1M
  • 1Y
0.0100
Interactive AVTO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AVTO

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0900
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.74
Shares Outstanding (M) 74.28
30 Day Average Volume 3
Price/Book (mrq) 2.0349
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AVTO

No data available

Company Profile & Key Executives for AVTO

Avantogen Oncology, Inc. acquires and develops pharmaceutical compounds focused on the treatment of cancer. The Company has a portfolio of several compounds targeted against various cancers and cancer related diseases. Avantogen seeks to license the compounds at an early stage of development, and then develop and commercialize them by partnering with pharmaceutical companies.

William J Ardrey IVChairman/CEOAngela Bronow DavanzoCFO/Secretary
More Company Profile & Key Executives for AVTO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil